KLF12基因表达在HPV整合导致宫颈癌发病中的作用及机制研究

    Role and mechanism of KLF12 gene expression in cervical cancer caused by HPV integration

    • 摘要:
      目的 分析Krueppel样因子12(KLF12)基因表达在人乳头瘤病毒(HPV)整合导致宫颈癌(CC)发病中的作用及机制。
      方法 选取接受妇科手术的98例病人, 包括50例CC、25例HPV(+)正常宫颈上皮、23例宫颈上皮内瘤变(CIN)。获取各组样本基因组DNA, 并进行高通量病毒整合检测和质谱分析, 以确定整合位点和差异蛋白。使用基因表达谱交互分析CC组织和非CC组织中的HPV KLF12表达, 并分析KLF12表达与CC病人总生存率的相关性。通过免疫组织化学染色检测CC组织中KLF12的表达, 分析KLF12表达与临床病理特征的关系。体外实验将HeLa细胞分为KLF12敲低(si-KLF12)组和对照(si-NC)组, 通过CCK-8和EdU掺入试验测定细胞活力, Transwell试验检测细胞的迁移和侵袭能力。
      结果 在所有宫颈样本中, HPV整合的总体患病率为72.1%(137/190)。与正常组相比, CIN组和肿瘤组的HPV整合数量降低(P < 0.05), 且肿瘤组的HPV整合数量高于CIN组(P < 0.05)。就基因结构而言, HPV整合经常发生在CCAT1的内含子以及KLF5/KLF12之间的基因间区域。GEPIA26研究显示, KLF12升高的CC病人的生存期降低(P < 0.05)。免疫组织化学染色结果显示, 与正常宫颈组织相比, KLF12在宫颈癌组织中表达明显上调(P < 0.01)。体外细胞实验结果显示, 敲低KLF12可降低HeLa细胞增殖、迁移和侵袭能力。
      结论 KLF12可作为宫颈HPV感染和持续存在的暗示性候选风险位点, 并且KLF12在CC细胞系和组织中上调, 其高表达体外促进宫颈癌细胞的增殖和侵袭。

       

      Abstract:
      Objective To analyze the role and mechanism of Krueppel-like factor 12 (KLF12) gene expression in cervical cancer (CC) caused by human papilloma virus (HPV) integration.
      Methods A total of 98 patients undergoing gynecological surgery were selected, including 50 cases of CC, 25 cases of HPV(+) normal cervical epithelium, and 23 cases of cervical intraepithelial neoplasia (CIN). The genomic DNA of samples in each group was obtained, and high-throughput virus integration detection and mass spectrometry were performed to identify integration sites and differential proteins. Gene expression profiling interaction analysis was used to analyze HPV KLF12 expression in CC tissues and non-CC tissues, and the association of KLF12 expression with overall survival in CC patients was analyzed. The expression of KLF12 in CC tissues was detected by immunohistochemistry, and the relationship between KLF12 expression and clinicopathological features was evaluated. In experiments in vitro, HeLa cells were divided into KLF12 knockdown (si-KLF12) group and corresponding control (si-NC) group; cell viability was assessed by CCK-8 and EdU incorporation assays, respectively, and cell migration and invasion abilities were detected by Transwell assay.
      Results In all cervical samples, the overall prevalence of HPV integration was 72.1% (137/190). Compared with the normal group, the number of HPV integration in the CIN group and tumor group decreased (P < 0.05), and the number of HPV integration in the tumor group was higher than that in the CIN group (P < 0.05). In terms of gene structure, HPV integration frequently occurred in the intron of CCAT1 and the intergenic region between KLF5/KLF12. The GEPIA26 study showed that the survival of CC patients with elevated KLF12 was reduced (P < 0.05). The immunohistochemical staining results showed that compared with normal cervical tissue, KLF12 expression was significantly upregulated in cervical cancer tissue (P < 0.01).The results of in vitro cell experiments showed that KLF12 knockdown reduced the proliferation, migration, and invasion ability of HeLa cells.
      Conclusions KLF12 may serve as a suggestive candidate risk locus for cervical HPV infection and persistence. KLF12 is upregulated in CC cell lines and tissues, and its high expression promotes the proliferation and invasion of cervical cancer cells in vitro.

       

    /

    返回文章
    返回